Table 3 Comparison of responses before and after the training on pharmacovigilance regarding knowledge and attitude related questions
Knowledge related questions | Healthcare professionals (n, %) | p-value | |
|---|---|---|---|
Pre-survey correct response (n, %) | Post-survey correct response (n, %) | ||
Adverse Drug Reaction (ADR) definition | 56 (62.9) | 89 (100) | < 0.001 |
Pharmacovigilance (PV) definition | 56 (62.9) | 84 (94.4) | < 0.001 |
Most important purpose of Pharmacovigilance | 47 (52.8) | 86 (96.6) | < 0.001 |
A serious adverse event in Nepal that should be reported to a regulatory body within | 20 (22.5) | 79 (88.8) | < 0.001 |
Rare Adverse Drug Reactions can be identified in the following phase of the clinical trial | 32 (36) | 78 (87.6) | < 0.001 |
Which of the following methods is commonly employed by pharmaceutical companies to monitor? | 55 (61.8) | 79 (88.8) | < 0.001 |
Do you think ADR reporting is professional responsibility for you | 78 (87.6) | 89 (100) | < 0.001 |
The healthcare professionals responsible for reporting ADR in a hospital is/are | 82 (92.1) | 87 (97.8) | < 0.001 |
Do you know about the existence of a National PV program in Nepal | 39 (43.8) | 88 (98.9) | < 0.001 |
In Nepal, which regulatory body is responsible for monitoring ADR | 39 (4.8) | 82 (96.1) | < 0.001 |
Where the international center for ADR monitoring is located | 40 (44.9) | 86 (96.6) | < 0.001 |
One of the following agencies in the USA involved in drug safety issues | 50 (56.2) | 84 (94.4) | < 0.001 |
Attitude related statements | Pre-Survey Agreement (n, %) | Post-Survey Agreement (n, %) | p-value |
Reporting of ADRs as the exploration of mistakes of health professionals | 21 (23.6%) | 59 (66.3%) | < 0.001 |
Reporting of adverse drug reaction is necessary | 31 (34.8%) | 89 (100%) | < 0.001 |
Establishing ADR monitoring center in every hospital | 69 (77.5%) | 84 (94.4%) | 0.001 |
Reporting ADR will increase patient safety | 39 (43.8%) | 89 (100%) | < 0.001 |